Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03549806 · ClinicalTrials.gov registry record
Stanford Cardiac Invasive Electrophysiology Novel Computer Experience
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 11
- Enrollment target
NCT03549806: Completed study, sponsored by Stanford University.
NCT03549806 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03549806 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
This study will test the ability of computer algorithms to predict successful ablation therapy for atrial arrhythmias.
Primary Outcome
Reduction in amount of arrhythmia per unit time, compared to prior to the procedure.
Interventions
- DIAGNOSTIC_TEST No Intervention. Test is computer algorithm.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2018-06-21 |
| Est. Completion | 2021-01-11 |
What the finished NCT03549806 record still lists
NCT03549806 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No Intervention. Test is computer algorithm. is the first listed.
NCT03549806 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03549806 about?
NCT03549806 is a clinical study titled "Stanford Cardiac Invasive Electrophysiology Novel Computer Experience". This study will test the ability of computer algorithms to predict successful ablation therapy for atrial arrhythmias.
What is the current status of trial NCT03549806?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2018-06-21. Estimated completion is 2021-01-11.
What interventions are being tested in trial NCT03549806?
The interventions under investigation include: No Intervention. Test is computer algorithm. (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03549806?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI